BioNexus Gene Lab (BGLC) Cash from Operations (2018 - 2026)
BioNexus Gene Lab's (BGLC) quarterly Cash from Operations came in at -$422491.0 in Q2 2026, up 42.74% year-over-year from -$295976.7 in Q2 2025, and down 186.1% quarter-over-quarter from -$147671.0 in Q1 2026.
Powered by 
Analysis
BioNexus Gene Lab (BGLC) Cash from Operations (2018 - 2026) Analysis & Trends
BioNexus Gene Lab has disclosed Cash from Operations across 9 years of filings, most recently posting -$422491.0 for Q2 2026.
- In Q2 2026, Cash from Operations rose 42.74% year-over-year to -$422491.0; the TTM figure through Jun 2026 stood at -$846565.0 (up 71.26% YoY), while the FY2025 annual figure was -$1.8 million, up 12.18% from the prior year.
- Cash from Operations came in at -$422491.0 for Q2 2026 at BioNexus Gene Lab, down from -$147671.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of $961062.0 in Q4 2025 to a low of -$1.6 million in Q3 2024.
- Average Cash from Operations over 5 years is -$320677.4, with a median of -$171820.0 recorded in 2022.
- Year-over-year, Cash from Operations plunged 2721.96% in 2024 and soared 338.43% in 2025.
- Over 5 years, Cash from Operations stood at $476739.0 in 2022, then plunged by 264.14% to -$782526.0 in 2023, then jumped by 128.01% to $219203.0 in 2024, then soared by 338.43% to $961062.0 in 2025, then slumped by 143.96% to -$422491.0 in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were -$422491.0 in Q2 2026, -$147671.0 in Q1 2026, and $961062.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | W.W. Grainger | 60.06 Bn | 59.47 Bn | 1.98 Bn | 444.00 Mn |
| 2 | Fastenal | 56.31 Bn | 56.11 Bn | 1.06 Bn | 265.70 Mn |
| 3 | Ferguson Enterprises | 43.05 Bn | 42.23 Bn | 2.32 Bn | 772.00 Mn |
| 4 | Reliance | 20.03 Bn | 19.79 Bn | 1.30 Bn | 162.20 Mn |
| 5 | Wesco International | 16.76 Bn | 15.95 Bn | 1.46 Bn | 53.70 Mn |
| 6 | Applied Industrial Technologies | 11.88 Bn | 11.75 Bn | 411.22 Mn | 165.00 Mn |
| 7 | Watsco | 11.87 Bn | 11.40 Bn | 578.93 Mn | -2.54 Mn |
| 8 | Avantor | 10.07 Bn | 9.77 Bn | 537.00 Mn | 178.20 Mn |
| 9 | Core & Main | 7.67 Bn | 7.52 Bn | 520.00 Mn | 82.00 Mn |
| 10 | BioNexus Gene Lab | 2.60 Mn | -922,180.04 | 12,982.00 | -422,491.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -422,491.00 |
| Mar 31, 2026 | -147,671.00 |
| Dec 31, 2025 | 961,062.00 |
| Sep 30, 2025 | -1.24 Mn |
| Jun 30, 2025 | -737,907.00 |
| Mar 31, 2025 | -824,072.00 |
| Dec 31, 2024 | 219,203.00 |
| Sep 30, 2024 | -1.60 Mn |
| Jun 30, 2024 | -672,275.00 |
| Mar 31, 2024 | -37,153.00 |
| Dec 31, 2023 | -782,526.00 |
| Sep 30, 2023 | -899,345.00 |
| Jun 30, 2023 | -23,823.00 |
| Mar 31, 2023 | -116,518.00 |
| Dec 31, 2022 | 476,739.00 |
| Sep 30, 2022 | 308,891.00 |
| Jun 30, 2022 | -195,969.00 |
| Mar 31, 2022 | -37,839.00 |
| Dec 31, 2021 | 483,007.00 |
| Sep 30, 2021 | 315,869.00 |